Sort
326,823 grants matching “clinical trial”
Weill Cornell Program of Excellence in Gene Therapy
$2,545,982Weill Medical College Of Cornell Univ · U01 · FY2005 · HL
Stroke with Transfusions Changing to Hydroxyurea
$2,545,955Russell E Ware · St. Jude Children'S Research Hospital · U01 · FY2009 · HL
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$2,545,939Lisa Marie Guay-Woodford · University Of Alabama At Birmingham · UL1 · FY2011 · RR
Novel Therapies for Muco-Obstructive Lung Diseases
$2,545,908Richard C Boucher · Univ Of North Carolina Chapel Hill · P01 · FY2012 · HL
Discovering and Exploiting Mechanisms of Neuroblastoma Therapy Resistance
$2,545,516John M Maris · Children'S Hosp Of Philadelphia · P01 · FY2024 · CA
Assessing the role of cerebrovascular brain injury and dysfunction in Alzheimerâs disease pathogenesis in the BEACoN Cohort
$2,544,663Michael A Yassa · University Of California-Irvine · R01 · FY2024 · AG
The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site
$2,544,202Charles Drescher · Swedish Medical Center, First Hill · UG1 · FY2023 · CA
HIV-1 Therapy with CCR5 mAB PRO 140-Overview
$2,544,127William C Olson · Progenics Pharmaceuticals, Inc. · U19 · FY2007 · AI
Transcutaneous Phrenic Nerve Stimulation for Treating Opioid Overdose
$2,544,126Howard Levin · Coridea, Llc · UH3 · FY2025 · DA
Protective immunity following dengue virus natural infections and vaccination
$2,544,113Eva Harris · University Of California Berkeley · P01 · FY2021 · AI
DEVELOPMENT/TESTING OF ARTIFICIAL RETINAS FOR THE BLIND
$2,544,106Second Sight Medical Products, Inc. · R24 · FY2000 · EY
The role of stem cells in skeletal health and disease
$2,544,014Pamela G Robey · National Institute Of Dental & Craniofacial Research · ZIA · FY2021 · DE
An ultra-long-acting oral treatment for opioid use disorder
$2,543,976Andrew Martin Bellinger · Lyndra Therapeutics, Inc. · UG3 · FY2018 · DA
The Challenge of Individualizing Treatments for Patients with Breast Cancer
$2,543,942Steven J. Katz · University Of Michigan At Ann Arbor · P01 · FY2015 · CA
MRI Based Presymptomatic Prediction of ASD
$2,543,872John R Pruett · Washington University · R01 · FY2024 · MH
North Central Cancer Treatment Group
$2,543,699Jan C Buckner · Mayo Clinic Rochester · U10 · FY2007 · CA
Novel Therapies to Improve Renal and Cardiac Allograft Outcomes
$2,543,579Anil K Chandraker · Brigham And Women'S Hospital · U01 · FY2013 · AI
Carbohydrate-based Therapy for Lung Disease
$2,543,475John V Fahy · University Of California, San Francisco · P01 · FY2020 · HL
Toward Safer Gene Therapy for Hemophilia A
$2,542,930Roland W. Herzog · Indiana University Indianapolis · P01 · FY2023 · HL
Toward Safer Gene Therapy for Hemophilia A
$2,542,930Roland W. Herzog · Indiana University Indianapolis · P01 · FY2025 · HL
Statistical Methods for Cancer Clinical Trials
$2,542,900Michael R Kosorok · Univ Of North Carolina Chapel Hill · P01 · FY2010 · CA
HPV Vaccine Trial
$2,542,862Allan Hildesheim · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA
Multiethnic Study of Type 2 Diabetes Genes
$2,542,751David Altshuler · Broad Institute, Inc. · U01 · FY2010 · DK
Shapeshifters in Cancer: Defining the Fundamental Forces of Leukemia Evolution
$2,542,500Dan Landau · Weill Medical Coll Of Cornell Univ · DP2 · FY2018 · CA
Novel Econometric Research Designs (NERD) to Help End Addiction Long-term
$2,542,500Ali Jalali · Weill Medical Coll Of Cornell Univ · DP2 · FY2024 · DA